CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

NCT04151342 · clinicaltrials.gov ↗

RECRUITING

Status

5500

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Malignancies Multiple
Malignant Solid Tumor
Cancer, Therapy-Related
Molecular Sequence Variation
Genetic Alteration
Gene Fusion
Receptor Tyrosine Kinase Gene Mutation
RTK Family Gene Mutation
Ras (Kras or Nras) Gene Mutation

Interventions

DRUG: Cancer treatment with tyrosine kinase inhibitors (TKIs) or other molecularly targeted therapeutic agents.
OTHER: Patient-reported outcomes (PROs)

Sponsor

University Health Network, Toronto

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]